The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter randomized phase II trial of AHCC combined with multidisciplinary treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma (jRCTs051200029).
 
Suguru Yamada
No Relationships to Disclose
 
Daisuke Hashimoto
No Relationships to Disclose
 
So Yamaki
No Relationships to Disclose
 
Hiroyuki Ishida
No Relationships to Disclose
 
Masashi Kanai
Stock and Other Ownership Interests - Therabiopharma Inc.
Speakers' Bureau - AstraZeneca; MSD
Research Funding - JMS Co., Ltd
 
Toru Watanabe
No Relationships to Disclose
 
Kazuto Shibuya
No Relationships to Disclose
 
Tsutomu Fujii
No Relationships to Disclose
 
Kenjiro Okada
No Relationships to Disclose
 
Kenichiro Uemura
No Relationships to Disclose
 
Masamichi Hayashi
No Relationships to Disclose
 
Hideki Takami
No Relationships to Disclose
 
Keiko Kamei
No Relationships to Disclose
 
Ippei Matsumoto
No Relationships to Disclose
 
Satoshi Hirano
No Relationships to Disclose
 
Yuichi Nagakawa
No Relationships to Disclose
 
Akimasa Nakao
No Relationships to Disclose
 
Kenta Murotani
Honoraria - AstraZeneca; Chugai Pharma; Taiho Pharmaceutical
 
Hideki Ishikawa
No Relationships to Disclose
 
Sohei Satoi
Research Funding - Amino Up; Boston Scientific; Koukamei HSM. Co. Ltd; Nihon Servier